Pacific Biosciences of California, Inc. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
Pacific Biosciences of California, Inc. (PACB) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $175.87 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $175.87M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $219.69M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $219.01M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $246.17M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2026-06-30 | $175.87M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $219.69M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $219.01M 10-K · filed 2026-02-25 |
| 2025-09-30 | $246.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $263.41M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $300.16M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $334.56M 10-K · filed 2025-03-17 |
| 2024-09-30 | $412.44M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $446.63M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $490.26M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $571.17M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $735.96M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $771.14M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |